ESR1 and type 2 diabetes mellitus: Studies have shown that lipocalin and insulin resistance form a vicious circle that exacerbates type 2 diabetes, and that modulation of estrogen receptors by diet or pharmacological intervention can improve lipocalin resistance and thus insulin resistance in type 2 diabetes (Chattopadhyay et al., 2022).